-
Posted by
Two Blokes Jul 29 -
Filed in
Stock
-
6 views
Merck & Co Inc (NYSE:MRK, ETR:6MK) shares moved lower in early trade as the pharmaceutical company reported second quarter earnings that fell short of estimates. Revenue for the quarter came in at $15.8 billion, down 2% year-over-year and below consensus expectations of approximately $15.75 billion.
